“In the next couple of years, I'd like to see that [the roughly ten years and billions of dollars it takes to design one drug] cut down in a matter of months, instead of years. That's what I think is possible. Perhaps even faster.”
CEO, Google DeepMind and Isomorphic Labs; 2024 Nobel laureate in Chemistry
Said Sep 12, 2025Deadline Dec 31, 2027Bloomberg Television interview (Bloomberg News write-up), 12 September 2025
Resolves against demonstrated design-to-candidate timelines at Isomorphic Labs and peers by end-2027; Isomorphic has not yet started a clinical trial.